Human 3 with Brom and Sam

tmp

Joe Moore is the CEO & Co-Founder of Psychedelics Today - the largest and longest running podcast and media operation in psychedelics.  In this episode, Joe and I discuss the hottest topics in psychedelics:  Joe Rogan, the dark forces at work in the psychedelics industry, the problem with decriminalization and amongst many other things, we speculate on how fermentation could put the drug cartels out of business (cocaine kombucha anyone?).  And of course, we touch on Psychedelics Today's new training program - Vital:  https://www.vitalpsychedelictraining.com/

This is an episode you don't want to miss.   

Joe earned a B.A. at Plymouth State University in Philosophy and has been studying psychedelics since 2001. After working for 20 years in software, Joe is dedicated to working towards improved drug policy and greater inclusion of psychedelics in culture. In 2016, Joe co-founded Psychedelics Today, a world-leading psychedelic education and media platform. The popular Psychedelics Today podcast has been downloaded over 2.4-million times, and the Psychedelics Today Psychedelic Education Center has enrolled over 9,000 students in psychedelic training e-learning courses.

🎧 Listen to Psychedelics Today:  https://psychedelicstoday.com/

💰 Check out Brom's psychedelic VC fund:  https://www.empath.vc

⏰ Timestamps: 

0:00 - intro and Joe’s background + meeting Stan Grof & Graham Hancock + Joe’s old podcast: Occult Sentinel

6:30 - we talk about Joe Rogan

8:00 - the drug war / DEA and how it impacts drug development

12:00 - the dark forces and shady actors playing in the psychedelics industry

18:00 - Vital: the Psychedelics Today psychedelic guide training program

25:30 - psychedelic pharma vs recreational & decrim + more on the drug war

31:00 - Joe’s take on Decriminalize Nature, or as he would call it: Decriminalize Some Nature

36:00 - could genetically engineered yeast and biofermentation defund cartels and end the drug war?

39:00 - the bipartisan support behind psychedelic policy reform + could Texas be the center of the psychedelic revolution?

41:30 - Joe’s views on the ethical challenges of psychedelic capitalism

48:00 - What’s going on in Oregon with Measure 109?

50:00 - are Psychedelic Assisted Experiences the next wave of the industry?

51:00 - How has decrim impacted Denver?

55:00 - Joe’s cautious take on the outlook for psychedelic businesses + competition from decrim and religious groups (Psychedelic Episcopalians?)

Tom Feegel is the Founder and CEO of Beond.  Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.  

In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction.  Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.    

https://www.beond.us   

Mycrodose's CEO Chad Conner and CSO Frank Kochinke return to the podcast to tell us about:   

⭐️  Follow Mycrodose:  https://mycrodosethera.com/ 

🔥. Follow Brom:  https://www.twitter.com/therealbrom 

⏰  Timestamps:  

Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.  

Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders.  Mindstate participated in Y Combinator in 2021.   

Check out Mindstate @ https://www.mindstate.design/

Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the integration of tech.  

Check out Nue.Life here:  https://nue.life/   

⏰  Timestamps:  

0:00 intro and Juan Pablo’s backstory 

5:30 how Nue Life got started  

11:00 the Nue Life patient experience   

20:40 the intersection of data and mental health 

32:30 competition in the Ketamine landscape  

37:00 is ketamine addictive?  

45:00 the future of at-home ketamine and the Ryan Haight act 

49:15 legal psilocybin in Oregon? 

53:30 what’s next for Nue Life?

Eesmyal Santos-Brault & Dr. Pamela Kryskow from Quantified Citizen talk about Quantified Citizen the app, and the results of Quantified Citizen's first study:  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.  

Check out the paper here:  https://www.nature.com/articles/s41598-021-01811-4

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc

The Integration Conversation is BACK with Nadia van der Heyden, Director of Sales and Marketing at Psygen.  

Recorded at Wonderland Miami.     

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc 

🐦 brom on twitter:  https://twitter.com/therealbrom 

💌 Email:   [email protected]

Brom discusses 10 interesting startup ideas for entrepreneurs in the psychedelics space.     

The ideas include applications of psychedelics to non mental health disorders, sexual disfunction, anti-aging, digital addiction, crypto, non-5ht2a drugs, gender specific issues, sustainable manufacturing and digital therapeutics.    

If you're an entrepreneur working on a psychedelic startup, we'd love to hear from you.  Please contact us at [email protected]   

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc 

📺 Watch on YouTube:  https://youtu.be/rpK8tzv2AaM

Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds.  In this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.    

💰 Invest in Brom's Psychedelic VC Fund: 

https://www.empath.vc  

📺 Watch on YouTube:

https://youtu.be/HmBsrUQYyOg 

🐦 brom on twitter:  

https://twitter.com/therealbrom 

🎇 Clips and other stuff on Instagram:  

https://instagram.com/theintegrationco 

💌 Email:   

[email protected]